Metropolitan Life Insurance Company (MetLife)’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-2,903
Closed -$164K 2655
2018
Q2
$164K Buy
2,903
+929
+47% +$47.1K ﹤0.01% 2064
2018
Q1
$83.5K Sell
1,974
-66
-3% -$2.83K ﹤0.01% 2366
2017
Q4
$109K Sell
2,040
-4,204
-67% -$222K ﹤0.01% 2261
2017
Q3
$279K Buy
6,244
+37
+0.6% +$1.69K ﹤0.01% 2072
2017
Q2
$302K Hold
6,207
﹤0.01% 2064
2017
Q1
$449K Buy
6,207
+398
+7% +$26.3K ﹤0.01% 1724
2016
Q4
$332K Sell
5,809
-263
-4% -$24.1K ﹤0.01% 2026
2016
Q3
$777K Sell
6,072
-232
-4% -$29.7K 0.01% 1429
2016
Q2
$786K Buy
6,304
+847
+16% +$97.4K 0.01% 1404
2016
Q1
$456K Buy
5,457
+569
+12% +$46.9K ﹤0.01% 1634
2015
Q4
$484K Hold
4,888
﹤0.01% 1643
2015
Q3
$599K Hold
4,888
﹤0.01% 1521
2015
Q2
$750K Sell
4,888
-224
-4% -$37K 0.01% 1486
2015
Q1
$873K Hold
5,112
0.01% 1274
2014
Q4
$782K Hold
5,112
0.01% 1484
2014
Q3
$542K Hold
5,112
﹤0.01% 1667
2014
Q2
$777K Hold
5,112
0.01% 1527
2014
Q1
$658K Hold
5,112
﹤0.01% 1612
2013
Q4
$891K Hold
5,112
0.01% 1403
2013
Q3
$824K Buy
5,112
+274
+6% +$43.1K 0.01% 1407
2013
Q2
$642K Buy
+4,838
New +$683K 0.01% 1529

Other funds holding ELGX

Metropolitan Life Insurance Company (MetLife)'s ELGX Position: Q3 2018 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Endologix Inc (ELGX) in Q3 2018, closing a stake of 2,903 shares — an estimated $164K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ELGX in Q2 2013 and held it in 21 quarters. The position peaked at $891K in Q4 2013. 100 funds tracked by Wall St. Rank hold ELGX as of Q3 2018.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Endologix Inc position as of Q3 2018 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,903 Endologix Inc shares in Q3 2018, an estimated $164K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Endologix Inc in Q2 2013 and held it in 21 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Endologix Inc position peaked at $891K in Q4 2013.
  • 100 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2018.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2018, filed 14 Nov 2018.